Clinical probiotics are strains of beneficial bacteria that have been extensively studied for their health benefits in controlled clinical trials. These probiotics are selected based on their ability to survive the digestive process and colonize the gut, where they exert their beneficial effects. They have shown promising results in managing various health conditions such as irritable bowel syndrome, inflammatory bowel disease, diarrhea, and allergies. Clinical studies have demonstrated their role in improving gut health, modulating the immune system, and enhancing nutrient absorption. Prebiotics, on the other hand, are non-digestible fibers that serve as food for these beneficial bacteria, promoting their growth and activity. Together, probiotics and prebiotics form a powerful symbiotic combination for supporting digestive health and overall well-being.
Title : Results from a cross-sectional observational study examining irritable bowel syndrome patients six months after finishing their participation in the ViIBS trial
Jacek Piatek, Calisia University, Poland
Title : Gut microbiome as a driver of healthy ageing
Thi Thu Hao Van, RMIT University, Australia
Title : Treating irritable bowel syndrome patients with a balanced multi-strain synbiotic–results from a multi-center, randomized, double-blind, placebo-controlled clinical trial (the ViIBS trial)
Henning Sommermeyer, Calisia University, Poland
Title : Molecular mechanisms underlying the anti-atherogenic actions of probiotics
Dipak P Ramji, Cardiff University, United Kingdom
Title : Global regulatory trends on the use of probiotics and prebiotics in foods and food supplements
David Pineda Ereno, DPE International Consulting, Belgium
Title : Biochemical profile and nutripotential glimpses of Terminalia arjuna bark extract
Suriyavathana Muthukrishnan, Periyar University, India